Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizio Recanatini

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Future Medicinal Chemistry|December 12, 2018
How dynamic docking simulations can help to tackle tough drug targetsMaurizio Recanatini
Journal of Medicinal Chemistry|April 28, 2020
Drug Research Meets Network Science: Where Are We?Maurizio Recanatini, Chiara Cabrelle
Journal of Medicinal Chemistry|January 11, 2002
Looking for selectivity among cytochrome P450s inhibitorsAndrea Cavalli, Maurizio Recanatini
Current Pharmaceutical Design|November 17, 2004
Acetylcholinesterase inhibitors as a starting point towards improved Alzheimer's disease therapeuticsMaurizio Recanatini, Piero Valenti
Wires Mechanisms of Disease|March 23, 2023
Network modeling helps to tackle the complexity of drug-disease systemsMaurizio Recanatini, Luca Menestrina
Future Medicinal Chemistry|March 1, 2014
Structure-based design of small-molecule protein-protein interaction modulators: the story so farFederico Falchi, Fabiana Caporuscio, Maurizio Recanatini
Chemmedchem|January 29, 2008
Modeling HERG and its interactions with drugs: recent advances in light of current potassium channel simulationsMaurizio Recanatini, Andrea Cavalli, Matteo Masetti
Chemico-Biological Interactions|January 24, 2006
Computational approaches to the study of dual-site and peripheral site binding ache inhibitorsMaurizio Recanatini, Andrea Cavalli, Giovanni Bottegoni
Journal of Chemical Information and Modeling|November 15, 2008
Mechanical features of Plasmodium falciparum acyl carrier protein in the delivery of substratesFrancesco Colizzi, Maurizio Recanatini, Andrea Cavalli
Drug Discovery Today. Technologies|July 2, 2014
In silico antitarget screeningMaurizio Recanatini, Giovanni Bottegoni, Andrea Cavalli
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Future Medicinal Chemistry|December 12, 2018
How dynamic docking simulations can help to tackle tough drug targetsMaurizio Recanatini
Journal of Medicinal Chemistry|April 28, 2020
Drug Research Meets Network Science: Where Are We?Maurizio Recanatini, Chiara Cabrelle
Journal of Medicinal Chemistry|January 11, 2002
Looking for selectivity among cytochrome P450s inhibitorsAndrea Cavalli, Maurizio Recanatini
Current Pharmaceutical Design|November 17, 2004
Acetylcholinesterase inhibitors as a starting point towards improved Alzheimer's disease therapeuticsMaurizio Recanatini, Piero Valenti
Wires Mechanisms of Disease|March 23, 2023
Network modeling helps to tackle the complexity of drug-disease systemsMaurizio Recanatini, Luca Menestrina
Future Medicinal Chemistry|March 1, 2014
Structure-based design of small-molecule protein-protein interaction modulators: the story so farFederico Falchi, Fabiana Caporuscio, Maurizio Recanatini
Chemmedchem|January 29, 2008
Modeling HERG and its interactions with drugs: recent advances in light of current potassium channel simulationsMaurizio Recanatini, Andrea Cavalli, Matteo Masetti
Chemico-Biological Interactions|January 24, 2006
Computational approaches to the study of dual-site and peripheral site binding ache inhibitorsMaurizio Recanatini, Andrea Cavalli, Giovanni Bottegoni
Journal of Chemical Information and Modeling|November 15, 2008
Mechanical features of Plasmodium falciparum acyl carrier protein in the delivery of substratesFrancesco Colizzi, Maurizio Recanatini, Andrea Cavalli
Drug Discovery Today. Technologies|July 2, 2014
In silico antitarget screeningMaurizio Recanatini, Giovanni Bottegoni, Andrea Cavalli
Pageof 12